Figure 4.

Association of individual solid cancer development with risk of subsequent overall mortality. Diagnosis of individual solid cancer was treated as time-varying mutually exclusive events. Patients who did not develop subsequent solid cancer were used as reference. Hazard ratios and 95% confidence intervals are shown with forest plots in unadjusted (blue) and adjusted (red) models. (A) Autologous HCT. Adjusted factors include patient age at transplantation and the use of TBI. Skin and prostate cancers are excluded because no deaths occurred with these cancers. (B) Allogeneic HCT. Adjusted factors include patient age at transplantation, prior chronic GVHD, and the use of TBI.